Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
LALPATHLAB

Dr. Lal Pathlabs Share Price

 

 

Dr. Lal Pathlabs live price: ₹1680.8.

Dr. Lal Pathlabs Performance

  • Today's Low
  • ₹1,647
  • Today's High
  • ₹1,707
  • 52 Week Low
  • ₹1,273
  • 52 Week High
  • ₹1,770
  • Open Price₹1,704
  • Previous Close₹0
  • Volume221,584
  • 50 DMA₹1,491.51
  • 100 DMA₹1,465.94
  • 200 DMA₹1,465.77

Dr. Lal Pathlabs Chart

Investment Returns

  • Over 1 Month + 16.97%
  • Over 3 Month + 19.86%
  • Over 6 Month + 6.98%
  • Over 1 Year + 18.57%

Smart Investing Starts Here Start SIP with Dr. Lal Pathlabs for Steady Growth!

Invest Now

Dr. Lal Pathlabs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 55.8
  • PEG Ratio
  • 15.4
  • Market Cap Cr
  • 28,177
  • P/B Ratio
  • 11
  • Average True Range
  • 61.78
  • EPS
  • 31.48
  • Dividend Yield
  • 0.8
  • MACD Signal
  • 60.37
  • RSI
  • 66.15
  • MFI
  • 90.22

Latest Stock News Updates

Dr Lal PathLabs hits 20% upper band on strong Q4; brokerages stay positive

Dr. Lal PathLabs recorded a 16.6 per cent Y-o-Y rise in revenue from operations to 702 crore in Q4 FY26 from 659.8 crore in the year-ago period

Dr Lal PathLabs Q4FY26 results: Net profit falls 15%; revenue rises 16.6%

Diagnostics firm reports profit decline due to prior-year tax benefit, while revenue growth remains strong on higher sample volumes and improved test mix

Q4FY26 Quarterly Result Announced for Dr. Lal Pathlabs Ltd.

Healthcare Services company Dr. Lal Pathlabs announced Q4FY26 results Revenue increased by 16.6% in Q4FY26. EBITDA for Q4FY26 increased by 10.5% with a margin of 26.6%. PAT for Q4FY26 is Rs 132 crore. with a margin for of 18.8%. Final Dividend of 40% i.e. Rs. 4 per share. Cash and Cash equivalents as on 31st March, 2026 is Rs. 1,526 crore. Result PDF

Dr. Lal Pathlabs Financials

Dr. Lal Pathlabs Technicals

EMA & SMA

Current Price
₹1,680.80
+ 12.2 (0.73%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,573.18
  • 50 Day
  • ₹1,491.51
  • 100 Day
  • ₹1,465.94
  • 200 Day
  • ₹1,465.77

Resistance and Support

1688.9 Pivot Speed
  • R3 1,757.30
  • R2 1,737.20
  • R1 1,709.00
  • S1 1,660.70
  • S2 1,640.60
  • S3 1,612.40

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Dr. Lal Path Labs Ltd. is one of India’s leading diagnostic and healthcare service providers, offering a wide range of tests and services through a network of over 200 labs and 3,000 patient service centers across the country.

Dr Lal Pathlabs has an operating revenue of Rs. 2,762.90 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 24% is great, ROE of 20% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and around 16% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 47 which is a POOR score indicating inconsistency in earnings, a RS Rating of 78 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Services and a Master Score of B is close to being the best. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Dr. Lal Pathlabs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-04-30 Audited Results & Final Dividend
2026-01-30 Quarterly Results & Interim Dividend To consider other business matters. per share(80%)Final Dividend
2025-10-31 Qtr Results, Int.Dividend & Bonus issue
2025-07-31 Quarterly Results, Dividend & Others To consider other business matters. per share(80%)Final Dividend
2025-04-25 Audited Results & Final Dividend
Date Purpose Remarks
2026-06-26 FINAL Rs.4.00 per share(40%)Final Dividend
2026-02-05 INTERIM Rs.3.50 per share(35%)Third Interim Dividend
2025-11-07 INTERIM Rs.7.00 per share(70%)Second Interim Dividend
2025-08-06 INTERIM Rs.6.00 per share(60%)Interim Dividend
2025-06-06 FINAL Rs.6.00 per share(60%)Final Dividend
View Dr. Lal Pathlabs Dividend History Arrow
Date Purpose Remarks
2025-12-19 Bonus Rs.0.00 issue of equity shares in the ratio of 1:1 of Rs. 10/-.

Dr. Lal Pathlabs Shareholding Pattern

53.21%
18.62%
2.33%
17.18%
0%
6.55%
2.11%

Dr. Lal Pathlabs FAQs

Dr. Lal Pathlabs share price is ₹1,680 As on 22 May, 2026 | 08:22

The Market Cap of Dr. Lal Pathlabs is ₹28176.6 Cr As on 22 May, 2026 | 08:22

The P/E ratio of Dr. Lal Pathlabs is 55.8 As on 22 May, 2026 | 08:22

The PB ratio of Dr. Lal Pathlabs is 11 As on 22 May, 2026 | 08:22

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23